In modern urological practice, ureteral stents and catheters have become indispensable tools to treat a wide range of upper urinary tract conditions, such as kidney stones, tumors, strictures and infections. Over the past decades, many improvements have been made on designs and constitutive materials to improve stent efficacy. But they remain associated with several adverse effects that limit their value as tools for long-term urinary drainage: The most common are infections, encrustation, migration, and patient discomfort.
The ARTORG Urogenital Engineering group is specialized in developing innovative engineering approaches to diagnose and treat diseases of the urinary tract. With a strong focus in fluid mechanical modeling, it has developed a new testing platform for ureteral stents. Group head Francesco Clavica is part of the ENIUS initiative as expert in fluid mechanics, microfluidics and electrophysiology.
